These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1016 related items for PubMed ID: 31575706

  • 21. Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data Set.
    Puzo C, Labriola C, Sugarman MA, Tripodis Y, Martin B, Palmisano JN, Steinberg EG, Stein TD, Kowall NW, McKee AC, Mez J, Killiany RJ, Stern RA, Alosco ML.
    Alzheimers Res Ther; 2019 Jul 27; 11(1):64. PubMed ID: 31351489
    [Abstract] [Full Text] [Related]

  • 22. Apolipoprotein epsilon4 and neuropsychological performance in Alzheimer's disease and vascular dementia.
    McGuinness B, Carson R, Barrett SL, Craig D, Passmore AP.
    Neurosci Lett; 2010 Oct 08; 483(1):62-6. PubMed ID: 20678545
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R, Palmqvist S, Mattsson N, Andreasson U, Wallin A, Pålsson E, Jakobsson J, Herukka SK, Owenius R, Olsson B, Hampel H, Rujescu D, Ewers M, Landén M, Minthon L, Blennow K, Zetterberg H, Hansson O, Alzheimer’s Disease Neuroimaging Initiative.
    JAMA Psychiatry; 2014 Oct 08; 71(10):1183-91. PubMed ID: 25162367
    [Abstract] [Full Text] [Related]

  • 25. Neuroimaging basis in the conversion of aMCI patients with APOE-ε4 to AD: study protocol of a prospective diagnostic trial.
    Chen GQ, Sheng C, Li YX, Yu Y, Wang XN, Sun Y, Li HY, Li XY, Xie YY, Han Y.
    BMC Neurol; 2016 May 12; 16():64. PubMed ID: 27176479
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. White matter hyperintensities and their relationship to cognition: Effects of segmentation algorithm.
    Tubi MA, Feingold FW, Kothapalli D, Hare ET, King KS, Thompson PM, Braskie MN, Alzheimer’s Disease Neuroimaging Initiative.
    Neuroimage; 2020 Feb 01; 206():116327. PubMed ID: 31682983
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. APOE-ε4 modulates the association among plasma Aβ42/Aβ40, vascular diseases, neurodegeneration and cognitive decline in non-demented elderly adults.
    Shi D, Xie S, Li A, Wang Q, Guo H, Han Y, Xu H, Gan WB, Zhang L, Guo T, Alzheimer’s Disease Neuroimaging Initiative.
    Transl Psychiatry; 2022 Mar 29; 12(1):128. PubMed ID: 35351867
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The neuropsychology of normal aging and preclinical Alzheimer's disease.
    Caselli RJ, Locke DE, Dueck AC, Knopman DS, Woodruff BK, Hoffman-Snyder C, Rademakers R, Fleisher AS, Reiman EM.
    Alzheimers Dement; 2014 Jan 29; 10(1):84-92. PubMed ID: 23541188
    [Abstract] [Full Text] [Related]

  • 37. The Value of Brain Structural Magnetic Resonance Imaging Combined with APOE--ε4 Genotype in Early Diagnosis and Disease Progression of Senile Vascular Cognitive Impairment No Dementia.
    Zhao W, Yin C, Yu F, Wan L, Che S, Cui L.
    Contrast Media Mol Imaging; 2022 Jan 29; 2022():8613024. PubMed ID: 35317127
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment.
    Caselli RJ, Reiman EM, Locke DE, Hutton ML, Hentz JG, Hoffman-Snyder C, Woodruff BK, Alexander GE, Osborne D.
    Arch Neurol; 2007 Sep 29; 64(9):1306-11. PubMed ID: 17846270
    [Abstract] [Full Text] [Related]

  • 40. The use of angiotensin-converting enzyme inhibitors vs. angiotensin receptor blockers and cognitive decline in Alzheimer's disease: the importance of blood-brain barrier penetration and APOE ε4 carrier status.
    Ouk M, Wu CY, Rabin JS, Jackson A, Edwards JD, Ramirez J, Masellis M, Swartz RH, Herrmann N, Lanctôt KL, Black SE, Swardfager W.
    Alzheimers Res Ther; 2021 Feb 11; 13(1):43. PubMed ID: 33573702
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 51.